LIFE: Losartan Intervention for Endpoint Reduction in Hypertension Study: A Randomized Trial Against Atenolol. LIFE [] was a double-blind, randomized, parallel-group trial in 9193 hypertensive ...

As temperatures rise, so does the risk of heat-related illness—especially for people taking certain prescription drugs.

Harnessing the artificial intelligence-driven platform, IDentif.AI, researchers sought to uncover sex-specific drug ...

Between September 2003 and July 2004, participating GPs observed patients with essential hypertension who received once-daily treatment with losartan 50mg or 100mg (Lorzaar ®, MSD Munich-Haar ...

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and ...

Abstract The efficacy and safety of various doses of losartan potassium, a specific and selective angiotensin II receptor antagonist, were compared with those of placebo and enalapril maleate 20 mg in ...

Macleods Pharmaceuticals Limited on Monday recalled one lot of the blood pressure medication losartan after discovering trace amounts of a probable carcinogen. The recalled 100 mg/25 mg losartan ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...